TVGN
TVGN
NASDAQ · Biotechnology

Tevogen Bio Holdings Inc

$5.90
-0.40 (-6.35%)
As of Nov 21, 2:47 AM ET ·
TVGN vs Biotechnology Average
Profit Margin
TVGN -14.6%
Avg -192.3%
Rev Growth
TVGN +20.6%
Avg +13.7%

Biotechnology Peers

1013 stocks in sector
Symbol Name Price Change % Market Cap P/E Margin Growth Div Yield Analyst
TVGN Tevogen Bio Holdings Inc $5.90 -6.35% 33.22M — -14.6% +20.6% — Current
ABBV Abbvie Inc $286.20 +0.94% 501.19B 48.5 6.9% +1.8% 4.47% Strong buy Compare
AMGN Amgen Inc $435.64 -0.72% 236.00B 25.1 21.0% +11.8% 3.21% Hold Compare
GILD Gilead Sciences Inc $166.43 -0.06% 208.61B — 28.9% +2.6% 3.98% Strong buy Compare
VRTX Vertex Pharmaceuticals Inc $515.02 -1.08% 129.77B 32.6 32.9% +10.4% — Strong buy Compare
REGN Regeneron Pharmaceuticals $920.69 -0.29% 95.40B 19.8 31.4% +5.6% — Buy Compare
MRNA Moderna Inc $195.00 -2.17% 79.10B — -145.2% -53.4% — Hold Compare
NTRA Natera Inc $273.40 -5.70% 39.77B — -9.0% +41.1% — Strong buy Compare
BIIB Biogen Inc $249.59 +1.00% 37.15B 106.9 13.1% -0.9% — Buy Compare
RVMD Revolution Medicines Inc $161.20 +1.11% 35.03B — 4.4% +0.4% — Strong buy Compare
INSM Insmed Inc $141.33 -2.17% 32.21B — -210.5% +35.2% — Strong buy Compare
ROIV Roivant Sciences Ltd $38.66 -0.78% 28.01B — -3,629.2% -48.7% — Strong buy Compare
INCY Incyte Corp $114.63 -1.07% 23.54B 58.4 25.0% +14.8% — Hold Compare
UTHR United Therapeutics Corp $554.73 -0.78% 23.00B 18.7 41.9% +18.0% — Strong buy Compare
EXAS Exact Sciences Corp $104.91 +0.95% 20.03B — -6.4% +15.9% — Hold Compare
ALNY Alnylam Pharmaceuticals Inc $143.82 -2.71% 19.80B 7.3 8.5% +53.0% — Strong buy Compare
EXEL Exelixis Inc $64.63 -1.82% 16.19B 18.3 33.7% +12.9% — Hold Compare
NBIX Neurocrine Biosciences Inc $150.57 -3.84% 15.58B 22.2 16.7% +24.3% — Strong buy Compare
BBIO Bridgebio Pharma Inc $76.03 -2.75% 14.89B — -144.4% +86.3% — Strong buy Compare
BMRN Biomarin Pharmaceutical Inc $60.41 -1.64% 11.76B — 10.8% +15.4% — Strong buy Compare
HALO Halozyme Therapeutics Inc $91.35 -1.82% 10.61B 25.7 22.7% +28.4% — Strong buy Compare